	Despesa De Juros Sobre A Dívida		Data
AbbVie	USD 740M	40M	2025-06
Acadia Pharmaceuticals	USD 0	4.12M	2024-09
Agios Pharmaceuticals	USD 1.39B	85.53M	2025-09
ALKERMES	USD 4.65M	1.35M	2024-12
Alnylam Pharmaceuticals	USD 129.34M	84.94M	2025-12
Amgen	USD 653M	32M	2025-12
Biogen	USD 72.6M	12.6M	2025-06
BioMarin Pharmaceutical	USD 2.78M	199K	2025-12
Cytokinetics	USD 26.32M	2.06M	2025-09
Enanta Pharmaceuticals	USD 1.96M	620K	2024-12
Exelixis	USD 23.4M	3.9M	2023-09
Gilead Sciences	USD 255M	1000K	2025-12
Halozyme Therapeutics	USD 4.91M	615K	2025-12
Incyte	USD 582K	10K	2025-12
Ionis Pharmaceuticals	USD 18M	1000K	2025-09
Nektar Therapeutics	USD 6.02M	420K	2024-09
Neurocrine Biosciences	USD 1.1M	0	2024-03
Pfizer	USD 711M	59M	2025-12
Prothena	USD 352.63M	46.44M	2025-09
Regeneron Pharmaceuticals	USD 12.2M	7.1M	2025-12
Repligen	USD 5.41M	60K	2025-09
Rigel Pharmaceuticals	USD 2.06M	31K	2024-09
Sarepta Therapeutics	USD 7.56M	2.33M	2025-09
Teva Pharmaceutical Industries	USD 220M	17M	2025-12
Ultragenyx Pharmaceutical	USD 19M	4.85M	2025-12
Vertex Pharmaceuticals	USD 3.3M	0	2025-12
Xoma	USD 3.4M	150K	2024-06

Neurocrine Biosciences Despesa De Juros Sobre A Dívida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.